Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease

Digestion

Volumn 93, Issue 1, 2016, Pages 59-65

  Takahashi, Kenichiro ^a   Nishida, Atsushi ^a   Fujimoto, Takehide ^a   Fujii, Makoto ^a   Shioya, Makoto ^a   Imaeda, Hirotsugu ^a   Inatomi, Osamu ^a   Bamba, Shigeki ^a   Andoh, Akira ^a   Sugimoto, Mitsushige ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Firmicutes; Microbiota; Short chain fatty acids

Indexed keywords

BUTYRIC ACID; C REACTIVE PROTEIN; RNA 16S; BACTERIAL DNA; BUTYRIC ACID DERIVATIVE; RIBOSOME DNA;

ACTINOMYCES; ADULT; BACTEROIDES; BACTEROIDES UNIFORMIS; BIFIDOBACTERIUM; BLAUTIA; BLAUTIA FAECIS; CLINICAL ARTICLE; CLOSTRIDIUM LAVALENSE; CONFERENCE PAPER; CONTROLLED STUDY; CROHN DISEASE; EUBACTERIUM; FAECALIBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; MALE; MICROBIAL COMMUNITY; PRIORITY JOURNAL; ROSEBURIA INULINIVORAN; RUMINOCOCCUS; RUMINOCOCCUS TORQUES; SEQUENCE ANALYSIS; CASE CONTROL STUDY; CLOSTRIDIUM; DNA SEQUENCE; DYSBIOSIS; FECES; GENETICS; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ACTINOMYCES; ADULT; BACTEROIDES; BIFIDOBACTERIUM; BUTYRATES; CASE-CONTROL STUDIES; CLOSTRIDIUM; CROHN DISEASE; DNA, BACTERIAL; DNA, RIBOSOMAL; DYSBIOSIS; EUBACTERIUM; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; RUMINOCOCCUS; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA;

EID: 84955558823     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000441768     Document Type: Conference Paper

References (29)

1. Sheehan D, Moran C, Shanahan F: The microbiota in inflammatory bowel disease. J Gastroenterol 2015;50:495-507.
2. Goldsmith JR, Sartor RB: The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014;49:785-798.
3. Andoh A, Kuzuoka H, Tsujikawa T, Nakamura S, Hirai F, Suzuki Y, Matsui T, Fujiyama Y, Matsumoto T: Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol 2012;47:1298-1307.
4. Nagalingam NA, Lynch SV: Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:968-984.
5. Mizoguchi A, Mizoguchi E: Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol 2008;43:1-17.
6. Wirtz S, Neurath MF: Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev 2007;59:1073-1083.
7. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606.
8. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, Lennerz JK, Kishi C, Kc W, Carrero JA, Hunt S, Stone CD, Brunt EM, Xavier RJ, Sleckman BP, Li E, Mizushima N, Stappenbeck TS, Virgin HW 4th: A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 2008;456:259-263.
9. Kabi A, Nickerson KP, Homer CR, McDonald C: Digesting the genetics of inflammatory bowel disease: insights from studies of autophagy risk genes. Inflamm Bowel Dis 2012;18:782-792.
10. Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterology 2008;134:577-594.
11. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR: Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-13785.
12. Kang S, Denman SE, Morrison M, Yu Z, Dore J, Leclerc M, McSweeney CS: Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm Bowel Dis 2010;16:2034-2042.
13. Frank DN, Robertson CE, Hamm CM, Kpadeh Z, Zhang T, Chen H, Zhu W, Sartor RB, Boedeker EC, Harpaz N, Pace NR, Li E: Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:179-184.
14. Sartor RB: The intestinal microbiota in inflammatory bowel diseases. Nestle Nutr Inst Workshop Ser 2014;79:29-39.
15. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, Langella P: Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-16736.
16. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976;70:439-444.
17. Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A: Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 2013;28:613-619.
18. Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M: Development of a prokaryotic universal primer for simultaneous analysis of Bacteria and Archaea using next-generation sequencing. PLoS One 2014;9:e105592.
19. Wang Q, Garrity GM, Tiedje JM, Cole JR: Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261-5267.
20. Kostic AD, Xavier RJ, Gevers D: The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 2014;146:1489-1499.
21. Nagalingam NA, Lynch SV: Role of the microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2012;18:968-984.
22. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ: Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 2000;66:1654-1661.
23. Liu C, Finegold SM, Song Y, Lawson PA: Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2008;58:1896-1902.
24. Duncan SH, Aminov RI, Scott KP, Louis P, Stanton TB, Flint HJ: Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol 2006;56:2437-2441.
25. De Preter V, Machiels K, Joossens M, Arijs I, Matthys C, Vermeire S, Rutgeerts P, Verbeke K: Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. Gut 2015;64:447-458.
26. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013;504:446-450.
27. Hall JA, Bouladoux N, Sun CM, Wohlfert EA, Blank RB, Zhu Q, Grigg ME, Berzofsky JA, Belkaid Y: Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008;29:637-649.
28. Andoh A, Fujiyama Y, Hata K, Araki Y, Takaya H, Shimada M, Bamba T: Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells. Clin Exp Immunol 1999;118:23-29.
29. Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, Matsui T, Matsumoto T, Benno Y, Fujiyama Y: Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment Pharmacol Ther 2009;29:75-82.